No, the FDA explicitly warns against unregulated whitening injections
It received an FDA warning letter in September 2025 for misleading compounded semaglutide marketing claims, launched a compounded semaglutide pill in February 2026 that was referred to the DOJ within days and pulled within 48 hours, was sued by Novo Nordisk for patent infringement, and then reached a deal with Novo Nordisk in March 2026 to offer branded Ozempic directly through the platform
This protects you from cascading late fees if an unexpected expense disrupts your cash flow
"During this time, insurance companies can't deny you coverage or charge you more because of health problems." Beyond this period, you might still qualify for guaranteed issue rights in certain situations like if you lose employer coverage, move out of your Medicare Advantage plan's service area, or if your Medicare Advantage plan leaves Medicare
Pull off the paper tab from the outer needle cap (See Figure D)
Patel developed called Glutaryl